The overall goal of this research program is to understand the affinities/avidities of the sites of interaction on T cell ab receptors (TCRs) for conventional peptide antigens or superantigens (SAgs) bound to major histocompatibility complex (MHC) Class II molecules and how the quality of that interaction affects the fate of the T cell in positive selection, negative selection or productive activation. Our experiments will be performed in vitro with recombinant soluble proteins. We will use mutational studies to determine in detail the sites of interaction of three staphylococcal SAgs, SEA, SEC3 and TSST-1 on mouse Vbeta3, Vbeta8.2 and Vbeta15 respectively. In addition, in biosensor surface plasmon resonance studies we will examine the contribution from Va and MHC class II to the quality of TCR Vbeta binding to these SAgs. In a separate set of experiments, we will prepare soluble TCRs from CD4 plus T cell hybridomas of known antigen/MHC reactivity derived from T cells that have been positively selected in transgenic mice bearing a single MHC class II molecule complexed to a single peptide. We will use these TCRs to compare the affinities/avidities required for positive selection, negative selection and T cell activation. The experiments will involve direct binding studies of soluble TCRs to MHC/peptide complexes and include construction of soluble multivalent TCRs with defined geometries. These experiments will test hypotheses which propose that TCR affinity determines the fate of developing T cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI017134-22
Application #
6328664
Study Section
Immunobiology Study Section (IMB)
Program Officer
Nabavi, Nasrin N
Project Start
1979-12-01
Project End
2001-11-30
Budget Start
2000-12-01
Budget End
2001-11-30
Support Year
22
Fiscal Year
2001
Total Cost
$184,594
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Clayton, Gina M; Wang, Yang; Crawford, Frances et al. (2014) Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity. Cell 158:132-42
Clambey, Eric T; Collins, Bernard; Young, Mary H et al. (2013) The Ikaros transcription factor regulates responsiveness to IL-12 and expression of IL-2 receptor alpha in mature, activated CD8 T cells. PLoS One 8:e57435
MacLeod, Megan K L; David, Alexandria; McKee, Amy S et al. (2011) Memory CD4 T cells that express CXCR5 provide accelerated help to B cells. J Immunol 186:2889-96
Dai, Shaodong; Murphy, Guinevere A; Crawford, Frances et al. (2010) Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Proc Natl Acad Sci U S A 107:7425-30
Stadinski, Brian D; Zhang, Li; Crawford, Frances et al. (2010) Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci U S A 107:10978-83
Stadinski, Brian D; Delong, Thomas; Reisdorph, Nichole et al. (2010) Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 11:225-31
Wang, Yibing; Becker, Dean; Vass, Tibor et al. (2009) A conserved CXXC motif in CD3epsilon is critical for T cell development and TCR signaling. PLoS Biol 7:e1000253
Rubtsova, Kira; Scott-Browne, James P; Crawford, Frances et al. (2009) Many different Vbeta CDR3s can reveal the inherent MHC reactivity of germline-encoded TCR V regions. Proc Natl Acad Sci U S A 106:7951-6
McKee, Amy S; Munks, Michael W; MacLeod, Megan K L et al. (2009) Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 183:4403-14
Huseby, Eric S; Crawford, Frances; White, Janice et al. (2006) Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide. Nat Immunol 7:1191-9

Showing the most recent 10 out of 77 publications